ContextVision Sees Strong Momentum in 2019 Across Medical Imaging and Digital Pathology Sectors
Summary
With sales growth across its medical imaging offerings and patent approval for its unique method for high-quality digital pathology data generation, this past quarter has set a strong foundation for the future of the company. “In Q4, we continued to strengthen our brand with new product initiatives and we also made important advancements in our partnerships with existing and prospective medical imaging customers. The product development timeline is extended to ensure INIFY meets the high demands in quality and robustness required by ContextVision. The company also achieved a major milestone in Q4 with its first digital pathology patent for its unique and objective data-generation method, Master Annotation. It’s our mission to offer powerful software solutions to support healthcare professionals in the daily decision-making process to deliver the best possible patient care.